In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...